Trimetazidine effects on mitochondria energetic activity

Trimetazidine effects on mitochondria energetic activity

Aim. To investigate how trimetazidine (TMZ) directly affects oxidative phosphorylation in intact mitochondria (MCH), isolated from the animals not undergoing ischemia-reperfusion process.Material and methods. Rat liver MCH were isolated by standard methods. Oxidative and phosphorylating MCH function...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. V. Eliseeva, S. V. Grachev, N. D. Egorova, M. G. Glezer, E. I. Astashkin
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2008-12-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	trimetazidine isolated mitochondria oxidation and phosphorylation
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1730
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Trimetazidine effects on intracellular Са2+ ion concentration in HL-60 human promyelocytes
by: E. I. Astashkin, et al.
Published: (2008-10-01)

Anti-anginal and anti-ischemic effectiveness of trimetazidine MB in patients with unstable angina
by: M. G. Glezer, et al.
Published: (2009-02-01)

Reactive oxygen species production by blood leukocytes and its correction by trimetazidine MB in patients with acute coronary syndrome
by: M. G. Glezer, et al.
Published: (2009-08-01)

The effect of trimetazidine on cardiac haemodynamics and mitochondrial function in wild‐type transthyretin amyloidosis
by: Bertil Thyrsted Ladefoged, et al.
Published: (2025-06-01)

Comparative study: trimetazidine versus olanzapine on cognitive dysfunction and behavioral changes in ketamine-induced psychosis model in mice
by: Yosra Magdy, et al.
Published: (2025-04-01)

AN EXPERIENCE OF TRIMETAZIDINE USAGE IN COMORBIDITY
by: I. V. Kochetkova, et al.
Published: (2018-04-01)

TRIMETAZIDINE THERAPY INFLUENCE ON HEART RATE VARIABILITY IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE
by: M. V. Novikova, et al.
Published: (2014-10-01)

Clinical effectiveness of long-term trimetazidine MB therapy in patients with cardio-respiratory disease (the results of an open, prospective multi-centre study)
by: N. M. Kolomoets, et al.
Published: (2009-12-01)

THE USAGE OF TRIMETAZIDINE IN COMPLEX TREATMENT OF HEART FAILURE
by: N. R. Paleev, et al.
Published: (2001-04-01)

Efficacy of Trimetazidine and Sulodexide in Patients with Microvascular Angina
by: S. A. Boldueva, et al.
Published: (2020-07-01)

Comparing effectiveness of adding prolonged trimetazidine or isosorbide dinitrate to beta-adrenoblocker therapy in stable angina patients
by: M. G. Glezer, et al.
Published: (2006-08-01)

Effectiveness of the original trimetazidine MR in patients with stable coronary heart disease and angina attacks resistant to trimetazidine generics (ETALON study)
by: A. V. Fendrikova, et al.
Published: (2011-08-01)

Pleiotropic effects of trimetazidine
by: O. V. Romashchenko, et al.
Published: (2013-08-01)

TRIMETAZIDINE MR EFFECTS ON THE PARAMETERS OF 24-HOUR ELECTROCARDIOGRAM MONITORING AND HEART RATE VARIABILITY
by: M. V. Novikova, et al.
Published: (2013-10-01)

CLINICAL EFFECTIVENESS OF THE MODIFIED RELEASE TRIMETAZIDINE IN MICROVASCULAR ANGINA
by: P. Yu. Galin, et al.
Published: (2016-12-01)

The use of the myocardial cytoprotector trimetazidine in a patient with angina as an example of off-label use
by: O. V. Tsygankova, et al.
Published: (2019-12-01)

THE PROBLEM OF INTERCHANGEABILITY OF DRUG PRODUCTS. TRIMETAZIDINE IS AN EFFECTIVE TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE
by: L. E. Chekuldaeva, et al.
Published: (2015-12-01)

Trimetazidine MB treatment in patients with chronic heart failure
by: T. E. Morozova, et al.
Published: (2010-06-01)

Synergistic interaction between trimetazidine and ketoprophen in mice
by: Daniela Carmen Ababei, et al.
Published: (2015-06-01)

Trimetazidine in chronic heart failure patients aged above 75 years
by: I. V. Ignatenko, et al.
Published: (1970-01-01)

RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM
by: Yu. M. Lopatin, et al.
Published: (2016-08-01)

A method for isolating and cryopreserving intact mitochondria with improved integrity and functionality
by: Arima Okutani, et al.
Published: (2025-06-01)

Trimetazidine MR effects on heart remodeling in stable coronary heart disease patients
by: E. M. Khurs, et al.
Published: (2007-02-01)

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION
by: N. A. Koziolova, et al.
Published: (2018-03-01)

Carbohydrate metabolism parameters in angina patients treated with metoprolol and its combination with trimetazidine
by: E. V. Bochkareva, et al.
Published: (2012-08-01)

The effectiveness of cytocardioprotection of patients with the moderately expressed post infarct dysfunction of left heart ventricle: the results of the randomization research of trimetazidine and athenolole
by: V. V. Kalyuzhin, et al.
Published: (2002-03-01)

The influence of trimetazidine hydrochloride on acute ischemia-reperfusion injury of endothelial cells and oxidative stress response of rat kidney
by: DU Yi, et al.
Published: (2017-01-01)

Trimetazidine: Activating AMPK Signal to Ameliorate Coronary Microcirculation Dysfunction after Myocardial Infarction
by: Xiaolong Qu, et al.
Published: (2025-01-01)

The effectiveness of trimetazidine and fabomotizole in the prevention of angina progression and improvement of life quality in patients in area of armed conflict
by: Z. Yu. Shakhbiyeva, et al.
Published: (2019-03-01)

Neuroprotective and anticonvulsant effect of trimetazidine in a PTZ-kindling model of mice through modulation of the IL-1β/IL-1R1 and HMGB-1/TLR-4 axis
by: Shahnawaz Ahmad, et al.
Published: (2025-08-01)

Effects of trimetazidine on oxidant-antioxidant balance and angiogenesis; an in vivo experimental study
by: Fethullah Kayan, et al.
Published: (2025-04-01)

MEMBRANE-SАVING ACTION OF TRIMETAZIDINE IN SUBJECTS WITH ACUTE MYOCARDIAL INFARCTION
by: S. V. Vasilyev, et al.
Published: (2014-12-01)

CYTOPROTECTION WITH TRIMETAZIDINE MB: RECENT DATA
by: I. G. Gordeev, et al.
Published: (2015-05-01)

Protective effects of trimetazidine and coenzyme Q10 on cisplatin-induced cardiotoxicity by alleviating oxidative stress and mitochondrial dysfunction
by: Li Zhao
Published: (2019-11-01)

MANAGEMENT OF ANGINA ATTACKS IN HEART FAILURE DUE TO NONCORONARY HEART DISEASE: TRIMETAZIDINE USAGE
by: M. Yu. Sitnikova, et al.
Published: (2015-11-01)

Metabolic plasticity in pancreatic cancer: The mitochondrial connection
by: Noemi Ghiglione, et al.
Published: (2025-02-01)

Is localized chemiosmosis necessary in mitochondria? Is Lee's TELP protonic capacitor hypothesis a reasonable model?
by: Todd P. Silverstein
Published: (2024-01-01)

EFFECTS OF TRIMETAZIDINE ON THE TRANSMITRAL BLOOD FLOW IN PATIENTS WITH DIASTOLIC HEART FAILURE
by: Yu. N. Fedulaev, et al.
Published: (2015-09-01)

Trimetazidine effects on red blood cell membrane lipids and necrosis area size in thrombolytic therapy of myocardial infarction
by: T. Yu. Rebrova, et al.
Published: (2009-04-01)

Evaluating the role of trimetazidine in preventing myocardial injury and contrast-induced nephropathy in patients undergoing percutaneous coronary interventions
by: Anshul Jain, et al.
Published: (2025-05-01)